Related Experiment Video
Updated: May 16, 2026
08:56
Evaluating the Role of Mitochondrial Function in Cancer-related Fatigue
Published on: May 17, 2018
Fatigue in immune-mediated neuropathies.
Ingemar S J Merkies1, Catharina G Faber
1Department of Neurology, Spaarne Hospital, Hoofddorp, The Netherlands. isjmerkies@planet.nl
Neuromuscular Disorders : NMD
|November 28, 2012
Summary
Fatigue is a common and disabling symptom in immune-mediated neuropathies like Guillain-Barré syndrome. This review explores its impact, mechanisms, and treatments for these debilitating conditions.
Area of Science:
- Neurology
- Immunology
- Clinical Medicine
Background:
- Fatigue is a prevalent and debilitating symptom in various immune-mediated neuropathies.
- Conditions discussed include Guillain-Barré syndrome, chronic immune-mediated demyelinating polyradiculoneuropathy, and multifocal motor neuropathy.
Purpose of the Study:
- To review the extent of fatigue in immune-mediated neuropathies.
- To examine the impact of fatigue on daily functioning and quality of life.
- To discuss potential mechanisms and therapeutic interventions for fatigue.
Main Methods:
- Literature review of studies on fatigue in immune-mediated neuropathies.
- Analysis of reported fatigue degrees, functional impacts, and quality of life data.
- Synthesis of proposed underlying mechanisms and treatment strategies.
Main Results:
- Fatigue significantly affects patients with immune-mediated neuropathies, impacting daily life.
- Various underlying mechanisms are suggested, requiring further investigation.
- Therapeutic interventions for fatigue in these conditions are being explored.
Conclusions:
- Fatigue is a critical symptom in immune-mediated neuropathies requiring focused attention.
- Understanding mechanisms is key to developing effective fatigue management strategies.
- Further research into targeted therapies is essential for improving patient outcomes.
Related Concept Videos
01:22Myasthenia Gravis ll: Pathophysiology
The disease process of myasthenia gravis begins at the neuromuscular junction, where antibodies attack key proteins needed for muscle activation. This immune reaction weakens signal transmission, leading to the characteristic muscle fatigue and weakness that define the condition.Immune-Mediated DamageIn most individuals, antibodies target acetylcholine receptors (AChRs) on the postsynaptic membrane of muscle cells. By blocking acetylcholine binding, these antibodies prevent the nerve signal...
01:21Fatigue
Fatigue occurs when materials rupture under repeated or fluctuating loads, even at stress levels far below their static breaking strength. It typically results in brittle failure, even for ductile materials. It is a critical consideration in designing machines and structural components subjected to repetitive or varying loads. The nature of these loadings can range from fluctuating loads like unbalanced pump impellers causing vibrations to repeatedly bending a thin steel rod wire back and forth...
01:22Diabetic Neuropathy
DefinitionDiabetic neuropathy is nerve damage caused by long-standing diabetes mellitus. It results directly from prolonged high blood sugar levels.PathophysiologyThe pathophysiology of diabetic neuropathy involves both metabolic and vascular disturbances triggered by chronic hyperglycemia.Metabolic injury: Elevated glucose levels activate the polyol pathway within nerve cells, leading to the accumulation of sorbitol and fructose. This increases oxidative stress, disrupts normal nerve...
01:19Multiple Sclerosis l: Introduction
Multiple sclerosis is a chronic autoimmune disease of the central nervous system (CNS) that affects the brain, spinal cord, and optic nerves. It is an inflammatory demyelinating disorder and a leading cause of neurological disability in young adults.EpidemiologyMS commonly begins between 20 and 40 years of age and is twice as common in women. Its exact cause remains unclear, but genetic susceptibility contributes, with higher risk in first-degree relatives and identical twins. A greater...
01:15Myasthenia Gravis: Diagnostic Tests
Myasthenia gravis is an autoimmune condition affecting neuromuscular transmission, causing generalized weakness in skeletal muscles. Initial diagnoses rely on patients' signs, symptoms, and medical history. The challenge lies in distinguishing myasthenia from other muscular dystrophies. An important diagnostic feature is the significant improvement of symptoms after administering anticholinesterase inhibitors.
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
The edrophonium test is a diagnostic tool for myasthenia gravis. It involves...
01:24Muscle Recovery and Fatigue
Muscle fatigue refers to the decline in a muscle's ability to maintain the force of contraction after prolonged activity. It primarily stems from changes within muscle fibers. Even before experiencing muscle fatigue, one may feel tired and have the urge to stop the activity. This response, known as central fatigue, occurs due to changes in the central nervous system, namely the brain and spinal cord. While there is no single mechanism that induces fatigue, it may serve as a protective response...